Drug Development

Expedite Robust Outcomes of Biologics Efficacy Studies Using Humanized Mice

This webinar explores how to leverage humanized mouse models to expedite preclinical research in biologic therapeutics.by providing a rigorous scientific framework and practical insights for l

Humanized Mice for the Assessment of the Safety of Immunotherapies

Biologics Drug Development Gets an Upgrade with Humanized Animal Models

JAX Study Director Aaron Rose, Ph.D., explores how biological therapeutics are reshaping the drug development process and why humanized models are essential for advancing biologics programs.

Designing Reproducible Preclinical Research Studies

During this seminar, we discuss unique experimental design considerations for mouse-based research.

The Consequences of Sex Bias in Preclinical Research

Omitting sex as a biological variable has several consequences. Watch this webinar to learn the scientific impact sex bias has on your research.

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies

During this webinar, we discuss preclinical data showcasing efficacy and safety testing of immunotherapies in immune humanized mouse models.

De-Risk Therapeutic Antibody Drug Development Using Humanized FcRn Platforms (Oct. 24, 2023)

In this webinar, we discuss the humanized FcRn platform, an effective tool that provides relevant PK data for candidate therapeutic antibodies and albumin-conjugated molecules.

In Vivo Platforms for Autoimmune Pharmacology: MS-EAE Capabilities

Watch this webinar to learn about Experimental Autoimmune Encephalomyelitis (EAE), which serves as the gold standard preclinical model for MS research.

Humanized Mice: Activity of Cytotoxic and Immunomodulatory IgG Antibodies

Anja Lux, PhD, Friedrich Alexander University, speaking at The Jackson Laboratory EU Symposium. A humanized mouse model to study activity of cytotoxic and immunomodulatory human IgG antibodies.

Humanized Mice: FcRn Biology

Simone Mester, PhD, Authera Biotech, speaking at The Jackson Laboratory EU Symposium. Of Mice and Men - FcRn biology and its implications in a therapeutic perspective.

Humanized Mice: Hematopoietic Stem Cells and Antibody-Mediated Depletion

Frank Lehmann, PhD, Cimeio Therapeutics, speaking at The Jackson Laboratory EU Symposium. Molecular shielding protects hematopoietic stem cells from antibody-mediated depletion.